BVF as of Dec. 31, 2018
Portfolio Holdings for BVF
BVF holds 55 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chemocentryx | 9.5 | $73M | 6.7M | 10.91 | |
| Array BioPharma | 8.8 | $68M | 4.7M | 14.25 | |
| Merus N V (MRUS) | 8.3 | $63M | 4.5M | 14.00 | |
| Kura Oncology (KURA) | 5.1 | $39M | 2.8M | 14.04 | |
| Blueprint Medicines (BPMC) | 4.0 | $31M | 575k | 53.91 | |
| Mirati Therapeutics | 3.8 | $29M | 689k | 42.42 | |
| Cytokinetics (CYTK) | 3.4 | $26M | 4.2M | 6.32 | |
| Arcus Biosciences Incorporated (RCUS) | 3.4 | $26M | 2.4M | 10.77 | |
| Five Prime Therapeutics | 3.4 | $26M | 2.8M | 9.30 | |
| Xoma Corp Del (XOMA) | 2.9 | $22M | 1.8M | 12.65 | |
| Xencor (XNCR) | 2.8 | $22M | 594k | 36.16 | |
| Ac Immune Sa (ACIU) | 2.8 | $21M | 2.2M | 9.45 | |
| Infinity Pharmaceuticals (INFIQ) | 2.7 | $21M | 17M | 1.18 | |
| Pieris Pharmaceuticals | 2.6 | $20M | 7.5M | 2.66 | |
| ArQule | 2.3 | $17M | 6.2M | 2.77 | |
| Concert Pharmaceuticals I equity | 1.9 | $14M | 1.2M | 12.55 | |
| Anaptysbio Inc Common (ANAB) | 1.8 | $14M | 220k | 63.79 | |
| Molecular Templates | 1.8 | $14M | 3.4M | 4.04 | |
| Calithera Biosciences | 1.7 | $13M | 3.3M | 4.01 | |
| Dicerna Pharmaceuticals | 1.7 | $13M | 1.2M | 10.69 | |
| Galmed Pharmaceuticals | 1.7 | $13M | 1.9M | 6.83 | |
| Verastem | 1.5 | $12M | 3.5M | 3.36 | |
| Biolinerx Ltd-spons | 1.5 | $11M | 26M | 0.44 | |
| Xenon Pharmaceuticals (XENE) | 1.5 | $11M | 1.8M | 6.31 | |
| Protagonist Therapeutics (PTGX) | 1.4 | $11M | 1.6M | 6.73 | |
| Spring Bk Pharmaceuticals In | 1.3 | $9.9M | 952k | 10.39 | |
| Replimune Group (REPL) | 1.2 | $9.0M | 900k | 10.00 | |
| Syndax Pharmaceuticals (SNDX) | 1.2 | $8.8M | 2.0M | 4.45 | |
| Vbi Vaccines | 1.1 | $8.3M | 5.2M | 1.60 | |
| Mei Pharma | 1.0 | $7.9M | 3.0M | 2.64 | |
| Argenx Se (ARGX) | 1.0 | $7.8M | 81k | 96.07 | |
| Corvus Pharmaceuticals (CRVS) | 0.9 | $6.9M | 1.9M | 3.67 | |
| Eiger Biopharmaceuticals | 0.9 | $6.9M | 675k | 10.16 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.9 | $6.8M | 2.9M | 2.35 | |
| Immune Design | 0.9 | $6.7M | 5.2M | 1.30 | |
| Forward Pharma A/s | 0.9 | $6.6M | 8.5M | 0.78 | |
| Spero Therapeutics (SPRO) | 0.7 | $5.2M | 843k | 6.15 | |
| Cti Biopharma | 0.7 | $5.1M | 6.9M | 0.73 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $5.0M | 253k | 19.75 | |
| Albireo Pharma | 0.6 | $4.9M | 201k | 24.53 | |
| Erytech Pharma Sa | 0.6 | $4.2M | 625k | 6.77 | |
| Principia Biopharma | 0.5 | $4.0M | 146k | 27.39 | |
| Oncomed Pharmaceuticals | 0.4 | $3.0M | 4.0M | 0.75 | |
| Contrafect | 0.4 | $2.9M | 1.9M | 1.53 | |
| Merrimack Pharma | 0.4 | $2.8M | 722k | 3.86 | |
| Alpine Immune Sciences | 0.3 | $2.4M | 643k | 3.68 | |
| Surface Oncology | 0.2 | $1.9M | 452k | 4.24 | |
| Vical | 0.2 | $1.5M | 1.3M | 1.18 | |
| Genocea Biosciences | 0.2 | $1.5M | 5.1M | 0.29 | |
| Essa Pharma (EPIX) | 0.2 | $1.2M | 580k | 2.10 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $961k | 2.3M | 0.42 | |
| Regulus Therapeutics | 0.1 | $978k | 1.1M | 0.93 | |
| Realm Therapeutics | 0.1 | $668k | 361k | 1.85 | |
| Loxo Oncology | 0.1 | $552k | 3.9k | 139.96 | |
| Ionis Pharmaceuticals (IONS) | 0.1 | $508k | 9.4k | 54.05 |
